A founder of a Massachusetts compounding pharmacy whose mold-tainted drugs sparked a deadly U.S. fungal meningitis outbreak in 2012 was resentenced on July 7 to 14-1/2 years in prison after a federal appeals court overturned his earlier 9-year term.